These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21258900)

  • 1. Evolution of the management of colorectal cancer using integrative medicine.
    Li ST; Chi P
    Chin J Integr Med; 2011 Jan; 17(1):73-9. PubMed ID: 21258900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Liu Y; May BH; Zhang AL; Guo X; Lu C; Xue CC; Zhang H
    Integr Cancer Ther; 2019; 18():1534735418817833. PubMed ID: 30526124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort Study on Prognosis of Patients with Metastatic Colorectal Cancer Treated with Integrated Chinese and Western Medicine.
    Zhang T; He WT; Zi MJ; Song G; Yi DH; Yang YF
    Chin J Integr Med; 2018 Aug; 24(8):573-578. PubMed ID: 29790064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.
    Facey K; Bradbury I; Laking G; Payne E
    Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to CONSORT Items in Randomized Controlled Trials of Integrative Medicine for Colorectal Cancer Published in Chinese Journals.
    Chen M; Cui J; Zhang AL; Sze DM; Xue CC; May BH
    J Altern Complement Med; 2018 Feb; 24(2):115-124. PubMed ID: 29068694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
    Kim WS; Lee HS; Lee JM; Kwak MS; Hwang SW; Park SH; Yang DH; Kim KJ; Myung SJ; Yang SK; Byeon JS
    J Gastroenterol Hepatol; 2017 Feb; 32(2):401-408. PubMed ID: 27418280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical application of positron emission tomography to colorectal cancer management.
    Arulampalam TH; Costa DC; Bomanji JB; Ell PJ
    Q J Nucl Med; 2001 Sep; 45(3):215-30. PubMed ID: 11788814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Treatment for Colorectal Cancer: A Comprehensive Approach.
    Block KI; Block PB; Gyllenhaal C
    J Altern Complement Med; 2018; 24(9-10):890-901. PubMed ID: 30247965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative Medicine for Relief of Nausea and Vomiting in the Treatment of Colorectal Cancer Using Oxaliplatin-Based Chemotherapy: A Systematic Review and Meta-Analysis.
    Chen MH; May BH; Zhou IW; Zhang AL; Xue CC
    Phytother Res; 2016 May; 30(5):741-53. PubMed ID: 26912094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of integrative medicine differs by age among pediatric oncology patients.
    Yun H; Romero SAD; Record B; Kearney J; Raghunathan NJ; Sands S; Mao JJ
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27639. PubMed ID: 30706689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in antibody derivatives against colorectal cancer; A review.
    Ghani S; Bahrami S; Rafiee B; Eyvazi S; Yarian F; Ahangarzadeh S; Khalili S; Shahzamani K; Jafarisani M; Bandehpour M; Kazemi B
    Life Sci; 2021 Jan; 265():118791. PubMed ID: 33220288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine.
    Gao ZY; Xu H; Shi DZ; Wen C; Liu BY
    J Ethnopharmacol; 2012 Jun; 141(2):578-83. PubMed ID: 21924336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New agents for colorectal cancer.
    Mulcahy ME; Benson AB
    J Natl Compr Canc Netw; 2003 Jan; 1(1):125-36. PubMed ID: 19764156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
    De Mattia E; Cecchin E; Toffoli G
    Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents.
    Cercek A; Saltz LB
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S47-51. PubMed ID: 19064406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of prescription regularity of traditional Chinese medicine for colorectal cancer based on data mining].
    Qi XJ; Chen XR; Mo JH; Li PX; Cai MY; Lan WN; Chen HR; Chen ZZ; Chen GM; Lin LZ
    Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(15):4016-4022. PubMed ID: 34472279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailoring therapy in colorectal cancer by PET-CT.
    Vriens D; de Geus-Oei LF; van der Graaf WT; Oyen WJ
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):224-44. PubMed ID: 19293770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer.
    Baek SK; Lee KT; Bae SB; Lee SC
    Korean J Intern Med; 2019 Nov; 34(6):1188-1196. PubMed ID: 31346151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.